LY2109761

This product is for research use only, not for human use. We do not sell to patients.

LY2109761
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
500mg$1550Check With Us
1g$2325Check With Us
5g$6275Check With Us

Cat #: V1361 CAS #: 700874-71-1 Purity ≥ 98%

Description: LY2109761 (LY-2109761; LY 2109761) is a novel, orally bioavailable and selective dual inhibitor of transforming growth factor beta receptor I/II (TGF-β receptor type I/II: TβRI/II) with potential antitumor activity.

References: Melisi D, et al. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther, 2008, 7(4), 829-840.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)441.52
Molecular FormulaC26H27N5O2
CAS No.700874-71-1
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 2 mg/mL (4.5 mM)r
Water: <1 mg/mLr
Ethanol:<1 mg/mL
Solubility In Vivo0.5% CMC+0.25% Tween 80: 16 mg/mL
SynonymsLY2109761; LY 2109761; LY-2109761
ProtocolIn VitroLY2109761 significantly inhibits the growth of L3.6pl/GLT soft agar colonies in a dose-dependent manner, approximately 33% at 2 μM and approximately 73% at 20 μM. Targeting TβRI/II kinase activity with LY2109761 (5 μM) almost completely inhibits basal migration of L3.6pl/GLT cells and TGF-β1-stimulated migration
In VivoLY2109761 (50 mg/kg, po) greatly reduced tumor volume and extended median survival to 45.0 days in mice. The occurrence of metastatic lesions was significantly reduced in mice treated with LY2109761, and in some of these mice, as indicated by GFP signaling, no metastatic lesions were found in the abdomen
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.2649 mL11.3245 mL22.6490 mL45.2981 mL
5mM0.4530 mL2.2649 mL4.5298 mL9.0596 mL
10mM0.2265 mL1.1325 mL2.2649 mL4.5298 mL
20mM0.1132 mL0.5662 mL1.1325 mL2.2649 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.